ENOV News and Press, Enovis Corporation

Wilmington, DE, May 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Bank of America Healthcare Conference: Ben ...

2024-05-05 17:30:00 ET Summary Enovis, the medtech leftover of Colfax, has seen solid growth, but reports highly adjusted earnings and recently has taken on quite some leverage. The company competes in a wide range of activities in the orthopedic market, facing competition from la...

2024-05-02 14:24:10 ET Enovis Corporation (ENOV) Q1 2024 Earnings Conference Call May 02, 2024, 08:00 AM ET Company Participants Kyle Rose - VP, IR Matthew Trerotola - CEO Phillip Berry - CFO Conference Call Participants Vik Chopra - Wells Fargo J...

Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...

2024-05-02 06:14:12 ET More on Enovis Corporation Don't expect pandemic backlog to fuel orthopedic sales, says Needham Seeking Alpha’s Quant Rating on Enovis Corporation Historical earnings data for Enovis Corporation Read the full article on Seeking...

Strong start to the year with sales growth of 27% on a reported basis and strong adjusted margin expansion Reported first-quarter net loss from continuing operations of $1.32 per share with adjusted earnings per diluted share of $0.50 Wilmington, DE, May 02, 2024 (GLOBE NEWSWIRE...

Enovis Corporation (ENOV) is expected to report $0.5 for Q1 2024

2024-05-01 11:49:28 ET More on Enovis Corporation Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript Don't expect pandemic backlog to fuel orthopedic sales, says Needham Needham sees orthopedics market slowing; favors Enovis, Paragon 28 Seeking Alpha&...

Wilmington, DE, April 17, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2024 financial results on Thursday, May 2, 202...

2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...